Dennis Hulme

Edison Investment Research

Dennis Hulme joined Edison's healthcare team in November 2014 after almost 10 years covering the healthcare and agriculture sectors as an analyst at BBY Stockbrokers. Previously, he worked as a research scientist with CSIRO and the University of Sydney. Dr. Hulme has a Ph.D. in veterinary science from the University of Sydney.

Recent Quotes

"RGS' Phase I Progenza safety trial met its primary endpoint."

— Dennis Hulme, Edison Investment Research (5/31/17)
more >



Due to permission requirements, not all quotes are shown.